Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Study on Chemoembolization Using Doxorubicin Drug-eluting Bead in Patients With Unresectable Hepatocellular Carcinoma

NCT01891539 is registered in ClinicalTrials.gov with International Group of Endovascular Oncology as lead sponsor.

NCT NCT01891539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01891539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Study on Chemoembolization Using Doxorubicin Drug-eluting Bead in Patients With Unresectable Hepatocellular Carcinoma
Lead sponsor
International Group of Endovascular Oncology
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2013
Completion date
December 31, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cell carcinoma non-resectable